Washington, Nov 5 : In a new study on mice, researchers have found that Nicotinamide, a form of Vitamin B3, in high doses may prevent lesions and symptoms associated with Alzheimer''s disease.
UC Irvine scientists are now conducting a clinical trial to determine its effect in humans.
Nicotinamide, was found to reduce the levels of a protein called phosphorylated tau that leads to the development of tangles, one of two brain lesions linked with Alzheimer''s.
The researchers found that the vitamin also strengthened scaffolding along which information travels in brain cells.